Nextech Invest
Nextech Invest reported 18 stocks worth $2.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (69.9%), PBLS (6.8%) and RLAY (5.5%). Compared with Q2 2026, the fund opened new positions in ATTO, ETRA and AVTX, added to ALMS and SLN, trimmed TYRA and sold out of ARVN.
Latest filing: what Nextech Invest did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 7 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() RVMD Revolution Medicines Inc | $1.6B | 69.9% | 7.6M | No change | 7 of 7 | |
| 2 | ![]() PBLS Parabilis Medicines Inc Com | $151M | 6.8% | 4.7M | No change | 2 of 7 | |
| 3 | ![]() RLAY Relay Therapeutics Inc | $122M | 5.5% | 6.8M | No change | 7 of 7 | |
| 4 | ![]() ORIC Oric Pharmaceuticals Inc | $96.5M | 4.3% | 7.2M | No change | 7 of 7 | |
| 5 | ![]() TYRA Tyra Biosciences Inc | $75.4M | 3.4% | 3.4M | −106K (−3%) | 7 of 7 | |
| 6 | ![]() ALMS Alumis Inc | $33.6M | 1.5% | 4.6M | +1M (+29%) | 7 of 7 | |
| 7 | ![]() ATTO Attovia Therapeutics Inc | $31.5M | 1.4% | 1.8M | New position | 1 of 7 | |
| 8 | ![]() KYMR Kymera Therapeutics Inc | $31.2M | 1.4% | 279K | No change | 6 of 7 | |
| 9 | ![]() ETRA Electra Therapeutics Inc | $29.7M | 1.3% | 2.6M | New position | 1 of 7 | |
| 10 | ![]() ZYME Zymeworks Inc | $29.5M | 1.3% | 1.1M | No change | 7 of 7 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() ARVN Arvinas Inc | $17.1M | 1.1M |
Reported value
last 7 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Nextech Invest 13F FAQ
What does Nextech Invest own?
Nextech Invest reported 18 stocks worth $2.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (69.9%), PBLS (6.8%) and RLAY (5.5%). The table above lists every position in the filing (the top 10 without an account).
What did Nextech Invest buy and sell in Q3 2026?
Compared with Q2 2026: 4 new positions, 2 added to, 1 trimmed and 1 sold out. New positions include ATTO, ETRA and AVTX. It sold all of ARVN.
When will Nextech Invest file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Nextech Invest's portfolio worth?
The Q3 2026 filing reports $2.2B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.













